A retrospective study of the proportional distribution of ABO blood types in SARS-CoV-2 patients in Jodhpur (western India)

Authors

  • Varsha Choudhary Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India https://orcid.org/0000-0001-5266-4659
  • Prabhat Kiran Khatri Dr Sampurnanand Medical College (SNMC), Microbiology Department, Jodhpur, India
  • Palak Khinvasara J-Class Solutions, Inc., Danbury, CT 06810, United States https://orcid.org/0009-0009-2851-2490
  • Gajender Kumar Aseri Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, India
  • Neelam Jain Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India https://orcid.org/0000-0003-1471-7419

DOI:

https://doi.org/10.3855/jidc.19376

Keywords:

COVID-19, ABO blood group, gender, age

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) has infected millions of people globally. Many recent studies have suggested that the ABO blood type may contribute to COVID-19 infection immunopathogenesis. We aimed to determine the proportional distribution of COVID-19 infection among ABO blood types.

Methodology: This retrospective research was conducted in the city of Jodhpur (Rajasthan), India. The research involved 1140 COVID-19 patients, whose medical records were available in blood banks. The data was evaluated statistically using IBM SPSS 26.

Results: The proportion of blood group B among infected patients was highest (37.36%). Among all the cases, blood group A had the highest odds ratio of 1.062 (CI 95%, 0.92-1.21, p = 0.412). All versus one blood group analysis also showed that blood group A (odds ratio = 1.062 [CI 95%, 0.92-1.22] p = 0.412) was more likely to be infected with COVID-19 than the remaining blood groups. In the year 2021, blood group B had the highest risk of COVID-19 infection (odds ratio = 1.138).

Conclusions: Based on our findings, the blood groups A and B are more likely to be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The overall average age for COVID-19 infection was lower, and the number of incidences in female patients was higher in 2021, relative to 2020. We found no evident relationship between COVID-19 vulnerabilities and blood group. A summary of the research is presented in Supplementary Figure 1.

Author Biographies

Varsha Choudhary, Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India

Research Scholar

Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India, 303002

Prabhat Kiran Khatri, Dr Sampurnanand Medical College (SNMC), Microbiology Department, Jodhpur, India

Professor

Dr. Sampurnanand Medical College (SNMC), Microbiology Department, Jodhpur, India

Palak Khinvasara, J-Class Solutions, Inc., Danbury, CT 06810, United States

Computational protein engineer, J-Class Solutions, Inc., Danbury, CT 06810, US

Gajender Kumar Aseri, Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, India

Pro-Vice Chancellor and Director, Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, India

Downloads

Published

2024-01-31

How to Cite

1.
Choudhary V, Khatri PK, Khinvasara P, Aseri GK, Jain N (2024) A retrospective study of the proportional distribution of ABO blood types in SARS-CoV-2 patients in Jodhpur (western India). J Infect Dev Ctries 18:27–33. doi: 10.3855/jidc.19376

Issue

Vol. 18 No. 01: January 2024

Section

Coronavirus Pandemic

License

Copyright (c) 2024 Varsha Choudhary, Prabhat Kiran Khatri , Palak Khinvasara , Gajender Kumar Aseri, Neelam Jain

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC